443 related articles for article (PubMed ID: 36987154)
1. Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.
Wu KY; Ashkar S; Jain S; Marchand M; Tran SD
Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987154
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
Wu KY; Joly-Chevrier M; Akbar D; Tran SD
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
[TBL] [Abstract][Full Text] [Related]
3. A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions.
Wu KY; Tan K; Akbar D; Choulakian MY; Tran SD
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514137
[TBL] [Abstract][Full Text] [Related]
4. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
5. An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers.
Shafiq M; Rafique M; Cui Y; Pan L; Do CW; Ho EA
J Control Release; 2023 Oct; 362():446-467. PubMed ID: 37640109
[TBL] [Abstract][Full Text] [Related]
6. Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.
Lynch C; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
Polymers (Basel); 2019 Aug; 11(8):. PubMed ID: 31434273
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
[TBL] [Abstract][Full Text] [Related]
8. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
9. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.
Bachu RD; Chowdhury P; Al-Saedi ZHF; Karla PK; Boddu SHS
Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29495528
[TBL] [Abstract][Full Text] [Related]
10. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
12. The Use of Polymer Blends in the Treatment of Ocular Diseases.
Arribada RG; Behar-Cohen F; de Barros ALB; Silva-Cunha A
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890326
[TBL] [Abstract][Full Text] [Related]
13. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
Durgun ME; Güngör S; Özsoy Y
J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
[TBL] [Abstract][Full Text] [Related]
14. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
Liu LC; Chen YH; Lu DW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
[TBL] [Abstract][Full Text] [Related]
15. Considerations for Polymers Used in Ocular Drug Delivery.
Allyn MM; Luo RH; Hellwarth EB; Swindle-Reilly KE
Front Med (Lausanne); 2021; 8():787644. PubMed ID: 35155469
[TBL] [Abstract][Full Text] [Related]
16. Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives.
Dludla SBK; Mashabela LT; Ng'andwe B; Makoni PA; Witika BA
Polymers (Basel); 2022 Aug; 14(17):. PubMed ID: 36080651
[TBL] [Abstract][Full Text] [Related]
17. Advances and limitations of drug delivery systems formulated as eye drops.
Jumelle C; Gholizadeh S; Annabi N; Dana R
J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
[TBL] [Abstract][Full Text] [Related]
18. A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation.
Wong CW; Metselaar JM; Storm G; Wong TT
Br J Ophthalmol; 2021 Dec; 105(12):1617-1622. PubMed ID: 33127826
[TBL] [Abstract][Full Text] [Related]
19. Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.
Ponzini E; Astolfi G; Grandori R; Tavazzi S; Versura P
Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931931
[TBL] [Abstract][Full Text] [Related]
20. Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application.
Peng X; Zhang T; Liu R; Jin X
Mol Cell Biochem; 2024 Jun; 479(6):1319-1333. PubMed ID: 37402019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
